PCG
FBT icon

Prosperity Consulting Group’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Prosperity Consulting Group’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$727K Sell
2,931
-150
-5% -$32.3K 0.03% 328
2026
Q1 		$619K Buy
3,081
+227
+8% +$47K 0.03% 323
2025
Q4 		$589K Buy
+2,854
New +$570K 0.03% 335

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Prosperity Consulting Group's FBT Position: Q2 2026 in Review

Prosperity Consulting Group reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 4.9% in Q2 2026, selling an estimated $32.3K and leaving 2,931 shares worth $727K. The position accounts for 0.03% of the portfolio, ranked #328.

Prosperity Consulting Group first reported a position in FBT in Q4 2025 and has held it in 3 quarters since. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Prosperity Consulting Group held 2,931 shares of First Trust NYSE Arca Biotechnology Index Fund worth $727K as of Q2 2026.
  • Prosperity Consulting Group sold 150 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $32.3K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.03% of Prosperity Consulting Group's portfolio in Q2 2026, its #328 holding.
  • Prosperity Consulting Group first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2025 and has held it in 3 quarters since.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Prosperity Consulting Group's 13F filing for Q2 2026, filed 13 Aug 2026.